Иммуногистохимические особенности лейкоцитарных инфильтратов печени онкологических больных
Published in Успехи современного естествознания • Jan 1, 2010
Authors:,,
И. Н. Кабановская
Т. М. Косынкина
О. В. Лебединская
Abstract
Potent antiviral activity and favourable safety of the treatment regimen were demonstrated. Furthermore, the results suggest that patients with breakthrough at week 4 may be rescued with an interferon-containing regimen. Clinical trials.gov number NCT01132313.
Subject
Finding related papers...
Discussions
(0)No comments yet
Be the first to share your thoughts!